| Code | 0854E | ||||||||||
| MA number | 20/0129/22-S | ||||||||||
| Product Form: | sol inj 60(12x5)x2 ml/10 mg (amp.PP) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Noridem Enterprises Ltd., Cyprus | ||||||||||
| Therapeutic Class: | 20 - ANTIEMETICA, ANTIVERTIGINOSA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | ampoule PP | ||||||||||
| Route of admin.: | Intramuscular or intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 24.05.2022 |
| Validity: | 24.05.2027 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric contraindication: | Yes |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Metoclopramide Noridem 5 mg/ml injekčný roztok 05_2022.pdf
|
| SPC: |
SPC_Metoclopramide Noridem 5 mg_ml injekčný roztok_08_2023.pdf
|
| Safety feature | Yes |
| Data update: | 25.08.2023 |
